Skip to main content

Table 1 Patient characteristics

From: Non-invasive method to detect high respiratory effort and transpulmonary driving pressures in COVID-19 patients during mechanical ventilation

Subject

Age

Gender

Main medical history

Position

PaO2/FiO2 ratio

pH

PaCO2 (mmHg)

RASS

Days of MV on study day

1

62

M

P

175

7.26

74

− 5

17

2

71

M

Asthma, ABPA

S

216

7.43

59

− 4

4

3

69

M

2 × PCI

S

116

7.25

94

− 4

22

4

73

M

COPD Gold II

S

262

7.22

64

− 3

38

5

51

M

Waldeström disease

S

156

7.36

57

− 4

14

6

49

M

P

78

7.42

47

− 5

6

7

66

M

OSAS, asthma

S

182

7.47

40

+ 1

42

8

63

M

Hypertension, obesity

S

118

7.31

97

− 4

46

9

53

M

Hodgkin

P

168

7.42

47

− 4

21

10

47

F

Hypertension

S

336

7.42

47

0

66

11

62

M

s-L

251

7.41

63

0

80

12

69

M

CABG

S

155

7.38

74

0

109

13

63

M

OSAS, hypertension

S

148

7.33

62

− 1

74

  1. ABPA allergic bronchopulmonary aspergillosis, AKI acute kidney injury, CABG coronary artery bypass grafting, COPD chronic obstructive pulmonary disease, OSAS obstructive sleep apnea syndrome, FiO2 fraction of inspired oxygen, MV mechanical ventilation, P prone, PaCO2 partial pressure of carbon dioxide in arterial blood, PaO2 partial pressure of oxygen in arterial blood, PCI percutaneous coronary intervention, S supine, s-L semi-lateral due to decubitus